High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.

Foeldvari, Ivan

High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis. [electronic resource] - The Journal of rheumatology May 2002 - 1079-83 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

0315-162X


Adolescent
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Arthritis, Juvenile--drug therapy
Child
Child, Preschool
Cyclooxygenase 1
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors--administration & dosage
Drug Therapy, Combination
Female
Humans
Isoenzymes--antagonists & inhibitors
Male
Meloxicam
Membrane Proteins
Patient Satisfaction
Prostaglandin-Endoperoxide Synthases
Thiazines--administration & dosage
Thiazoles--administration & dosage
Treatment Outcome